A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod (Formerly Called OK-101) Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).

Inclusion Criteria: 1. Aged 18 years of age or older. 2. Able and willing to provide written informed consent prior to any study-related procedures. 3. Presence of symptoms of neuropathic corneal pain for at least 3 months defined as the presence of ocular pain associated or not with ocular symptoms of burning, stinging, light sensitivity or discomfort. 4. In at least one eye: 1. Ocular pain score of 5 or more on 0-10 Visual Analogue Scale (VAS) AND in the same eye 2. In Vivo Confocal Microscopy (IVCM) changes of the subbasal corneal nerve plexus assessed by an Investigator who has rec…